https://www.indianpharmapost.com/rpg-life-sciences-posts-q2-fy24-pat-at-rs-2586-cr-148172023-10-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/indoco-remedies-posts-consolidated-q2fy24-pat-at-rs-3508-cr-148182023-10-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-pharma-receives-8-observations-from-usfda-for-pharma-division-at-kothur-148192023-10-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/zhimeng-biopharma-cb03-receives-orphan-drug-designation-from-the-usfda-148202023-10-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/ers-genomics-completes-licensing-agreement-with-syngene-international-148212023-10-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/india-should-take-global-leadership-with-holistic-healthcare-approach-sonowal-148222023-10-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/kkr-to-invest-in-life-sciences-firm-catalio-capital-management-148232023-10-23T00:00:00+05:30always0.9https://www.indianpharmapost.com/lg-chem-initiates-phase-2-clinical-trials-in-patients-with-defects-in-mc4r-pathway-causing-obesity-and-hyperphagia-148242023-10-23T00:00:00+05:30always0.9